Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Kronos Bio, Inc.
  6. Consensus
    KRON   US50107A1043

KRONOS BIO, INC.

(KRON)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Evolution of the average Target Price on KRONOS BIO, INC.
Target Price consensus revisions : last 18 months
Recommendations (Chart) KRONOS BIO, INC.
Analyst Recommendations on KRONOS BIO, INC.
02/28Piper Sandler Adjusts Kronos Bio's Price Target to $30 From $50, Reiterates Overweight Rat..
MT
2021KRONOS BIO : HC Wainwright Starts Kronos Bio at Buy With $35 Price Target
MT
2020KRONOS BIO : Jefferies Starts Kronos Bio at Buy With $36 Price Target
MT
2020KRONOS BIO : Piper Sandler Starts Kronos Bio at Overweight With $50 Price Target
MT
2020KRONOS BIO : Goldman Sachs Starts Kronos Bio at Buy With $45 Price Target
MT
2020KRONOS BIO : Cowen Initiates Coverage on Kronos Bio With Outperform Rating
MT
More recommendations
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 3,76 $
Average target price 29,50 $
Spread / Average Target 685%
High Price Target 36,00 $
Spread / Highest target 857%
Low Price Target 17,00 $
Spread / Lowest Target 352%
Consensus detail
Consensus revision (last 18 months)